Do overweight and obesity affect treatment response in major depression?
Our findings suggest that overweight and obesity characterize a subgroup of MDD patients with unfavorable treatment outcome.
Our results highlight the potential of prolonged use of CB2 agonists for managing chemotherapy-induced allodynia with a favorable therapeutic ratio marked by sustained efficacy and absence of tolerance, physical withdrawal, or CB1-mediated side effects.